| Michelle King, SLP | |
|
10294 E 96th St, Fishers, IN 46037-9497 | |
| (317) 288-7572 | |
| (317) 284-1765 |
| Full Name | Michelle King |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 10294 E 96th St, Fishers, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194892281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22003583A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle King, SLP 10294 E 96th St, Fishers, IN 46037-9497 Ph: (317) 288-7572 | Michelle King, SLP 10294 E 96th St, Fishers, IN 46037-9497 Ph: (317) 288-7572 |
News Archive
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Robertson Global Health Solutions Corporation announced today that it has formally completed its name change along with a 1 for 15 reverse stock split resulting in 11,543,346 shares of common stock currently issued and outstanding with 20,000,000 shares, par value $0.001, authorized. The Company also has 1,000,000 shares of preferred stock authorized, par value $0.001, with no preferred shares outstanding.
Scientists at The University of Texas MD Anderson who identified a protein's dual role in cancer promotion have discovered a way to shut it down, opening a potential new avenue for cancer treatment.
Researchers from LSTM and the University of Liverpool have successfully optimized a hit from a whole cell screening of a 10000-compound library to deliver the first novel fully synthetic and rationally designed anti-Wolbachia drug, AWZ1066S, which could potentially be used to treat onchocerciasis and lymphatic filariasis.
› Verified 1 days ago
Mrs. Lori Beth Henderson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12344 Quarry Face Ct, Fishers, IN 46037 Phone: 317-841-3528 | |
Dree Ellingworth, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10294 E 96th St, Fishers, IN 46037 Phone: 515-460-0537 | |
Amy Grimes, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8920 Tynan Way, Fishers, IN 46038 Phone: 317-207-1613 | |
Megan Elizabeth Rector, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 10280 Tournon Dr, Fishers, IN 46037 Phone: 812-987-4229 | |
Allyson Starks, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9957 Allisonville Rd, Fishers, IN 46038 Phone: 317-841-7005 | |
Rachel Schaller, SPEECH LANGUAGE PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12882 Longleaf Lane, Fishers, IN 46038 Phone: 317-771-5459 | |
Mrs. Kristina Rene Sturwold, MA, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9714 Fortune Dr, Fishers, IN 46037 Phone: 317-849-1409 Fax: 317-576-8084 |